Article
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Neutral
0.0
−100 Bearish
0
+100 Bullish
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
New York Times Business
Published
Mar 31, 2026 · 3:18 pm
Article ID
ym5jzaw
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This